Interleukin-6 and other cytokine blockade in COVID-19 hyperinflammation
Saved in:
| Main Authors: | Latika Gupta, Vikas Agarwal, Athimalaipet V Ramanan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2020-01-01
|
| Series: | Indian Journal of Rheumatology |
| Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=2;spage=65;epage=69;aulast=Gupta |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Possibilities of Hyperinflammation Correction in COVID-19
by: I. S. Simutis, et al.
Published: (2021-06-01) -
The treatment with Jusvinza reduces hyperinflammation and hypercoagulation in critical ill patients with COVID-19
by: Rafael Venegas Rodríguez, et al.
Published: (2021-11-01) -
Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID‐19 in type 2 diabetes
by: Fawaz Alzaid, et al.
Published: (2020-09-01) -
Hyperinflammation and blindness. Screening for ROSAH syndrome
by: Fernando Tornero-Romero, et al.
Published: (2025-03-01) -
Clinical Outcomes of Hospitalized Immunocompromised Patients With COVID-19 and the Impact of Hyperinflammation: A Retrospective Cohort Study
by: Zhang X, et al.
Published: (2025-03-01)